1. Home
  2. RDHL vs FMST Comparison

RDHL vs FMST Comparison

Compare RDHL & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • FMST
  • Stock Information
  • Founded
  • RDHL 2009
  • FMST 2005
  • Country
  • RDHL Israel
  • FMST Canada
  • Employees
  • RDHL N/A
  • FMST N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • FMST Other Metals and Minerals
  • Sector
  • RDHL Health Care
  • FMST Basic Materials
  • Exchange
  • RDHL Nasdaq
  • FMST Nasdaq
  • Market Cap
  • RDHL 6.8M
  • FMST 7.1M
  • IPO Year
  • RDHL N/A
  • FMST N/A
  • Fundamental
  • Price
  • RDHL $2.45
  • FMST $0.78
  • Analyst Decision
  • RDHL
  • FMST
  • Analyst Count
  • RDHL 0
  • FMST 0
  • Target Price
  • RDHL N/A
  • FMST N/A
  • AVG Volume (30 Days)
  • RDHL 121.9K
  • FMST 53.7K
  • Earning Date
  • RDHL 04-11-2025
  • FMST 01-01-0001
  • Dividend Yield
  • RDHL N/A
  • FMST N/A
  • EPS Growth
  • RDHL N/A
  • FMST N/A
  • EPS
  • RDHL N/A
  • FMST N/A
  • Revenue
  • RDHL $3,707,000.00
  • FMST N/A
  • Revenue This Year
  • RDHL $224.90
  • FMST N/A
  • Revenue Next Year
  • RDHL $82.69
  • FMST N/A
  • P/E Ratio
  • RDHL N/A
  • FMST N/A
  • Revenue Growth
  • RDHL N/A
  • FMST N/A
  • 52 Week Low
  • RDHL $2.40
  • FMST $0.55
  • 52 Week High
  • RDHL $20.28
  • FMST $3.48
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 26.68
  • FMST 42.90
  • Support Level
  • RDHL $2.64
  • FMST $0.78
  • Resistance Level
  • RDHL $2.90
  • FMST $0.90
  • Average True Range (ATR)
  • RDHL 0.23
  • FMST 0.09
  • MACD
  • RDHL 0.07
  • FMST 0.02
  • Stochastic Oscillator
  • RDHL 6.76
  • FMST 58.64

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.

Share on Social Networks: